Search

everythinglearnresearchcommunity

for

Search:↓

Recognizing LET and AITD can help diagnose SLE early for better treatment.

Juvenile-onset lupus patients have more severe symptoms and need stronger treatment.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Dupilumab effectively reduces alopecia areata symptoms in children with atopic dermatitis.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Inhibiting retinoic acid activates WNT signaling, potentially aiding hair disorder and skin cancer treatments.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Pediatric systemic lupus erythematosus is a severe autoimmune disease in children requiring early diagnosis and comprehensive management.

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

KAP8.1 protein is crucial for hair structure and interacts with keratin 85.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

SLE is more common among Nigerians than previously thought, especially in women, requiring early treatment.

Anti-phospholipid antibodies in SLE can cause thrombosis and bone necrosis.

TPO antibodies can help identify hypothyroid patients who still have symptoms despite normal TSH levels.

A patient with a new PLEC gene mutation showed symptoms of both muscular dystrophy and myasthenia gravis, which improved with steroid treatment.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Anti-CD19 therapy may help treat SLE and NMOSD.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

A woman's shingles infection triggered her first episode of a rare neurological disorder and blood vessel inflammation.